KURN Analyst Estimates: Price Targets, Revenue, Net Income, and EBIT Forecast - Kuros Biosciences AG - Alpha Spread

Kuros Biosciences AG
SIX:KURN

Watchlist Manager
Kuros Biosciences AG Logo
Kuros Biosciences AG
SIX:KURN
Watchlist
Price: 21.95 CHF 10.75%
Market Cap: 803.5m CHF
Have any thoughts about
Kuros Biosciences AG?
Write Note

Wall Street
Price Targets

KURN Price Targets Summary
Kuros Biosciences AG

There are no price targets for KURN.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Kuros Biosciences AG Competitors:
Price Targets
GLUE
Monte Rosa Therapeutics Inc
224% Upside
397030
AprilBio Co Ltd
19% Upside
HPHA
Heidelberg Pharma AG
345% Upside
VTGN
VistaGen Therapeutics Inc
342% Upside
RPTX
Repare Therapeutics Inc
345% Upside
KNSA
Kiniksa Pharmaceuticals Ltd
31% Upside
HALO
Halozyme Therapeutics Inc
17% Upside
STRO
Sutro Biopharma Inc
223% Upside

Revenue
Forecast

Revenue Estimate
Kuros Biosciences AG

Revenue forecast
is not available for
Kuros Biosciences AG

Operating Income
Forecast

Operating Income Estimate
Kuros Biosciences AG

Operating Income forecast
is not available for
Kuros Biosciences AG

Net Income
Forecast

Net Income Estimate
Kuros Biosciences AG

Net Income forecast
is not available for
Kuros Biosciences AG

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is KURN's stock price target?
Not Available

KURN doesn't have any price targets made by Wall Street professionals.

Back to Top